|
Volumn 2, Issue 1, 2005, Pages 185-187
|
Drug delivery global summit - Evaluating emerging technologies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
ANTINEOPLASTIC AGENT;
CHITOSAN;
COPOLYMER;
DRUG CARRIER;
HEPARIN;
INSULIN;
IONIC SURFACTANT;
MACROGOL;
POLYBUTYLENE TEREPHTHALATE;
POLYMER;
POLYSACCHARIDE;
PROTEIN;
RESPIRATORY TRACT AGENT;
ASTHMA;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOTOXICITY;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG CAPSULE;
DRUG DELIVERY SYSTEM;
DRUG DOSAGE FORM;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG POTENCY;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SOLUBILITY;
DRY POWDER;
GAMMA SCINTIGRAPHY;
GASTROINTESTINAL TRACT;
HUMAN;
METERED DOSE INHALER;
NANOTECHNOLOGY;
PARTICLE SIZE;
SIDE EFFECT;
TABLET FORMULATION;
VALIDATION PROCESS;
CHEMISTRY, PHARMACEUTICAL;
DELAYED-ACTION PREPARATIONS;
DRUG ADMINISTRATION ROUTES;
DRUG DELIVERY SYSTEMS;
HUMANS;
NANOSTRUCTURES;
PHARMACEUTICAL PREPARATIONS;
PROTEINS;
SOLUBILITY;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 12344252071
PISSN: 17425247
EISSN: None
Source Type: Journal
DOI: 10.1517/17425247.2.1.185 Document Type: Conference Paper |
Times cited : (5)
|
References (0)
|